2m 2m 2m 2m 2m 2m 2m
- $8.3MMarket Cap
- -27.48%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CBDMD (YCBD)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 79
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
U.S. stock futures rose on Monday as markets enter the Christmas week with abbreviated trading. The S&P 500, Nasdaq 100, and other major indices advanced in premarket trading. Key movers included Trump Media & Technology surging on a $6 billion merger completion, Kemper tumbling after a downgrade, and cbdMD rising despite missing earnings expectations. Markets are pricing in an 80.1% probability of the Federal Reserve maintaining current interest rates.
12/22/2025, 8:32 AM • Benzinga
U.S. stock futures rose on Monday as markets enter the Christmas week with abbreviated trading. The S&P 500, Nasdaq 100, and other major indices advanced in premarket trading. Key movers included Trump Media surging on a $6 billion merger completion, Kemper tumbling after a downgrade, and cbdMD rising despite missing earnings expectations. Markets are pricing in an 80.1% probability of the Federal Reserve maintaining current interest rates.
12/22/2025, 5:21 AM • Benzinga
Why Are cbdMD (YCBD) Shares Surging 55% After Hours?
cbdMD regained full compliance with NYSE American listing standards, resulting in a significant after-hours stock price increase of 54.64%.
12/12/2025, 2:45 AM • Benzinga
How Trump Has Fired Up Cannabis Stocks
Donald Trump's video on Truth Social praising hemp-derived CBD's health benefits triggered a significant surge in cannabis and CBD-related stocks, with some companies experiencing dramatic price increases.
09/29/2025, 4:12 PM • Investing
12 Health Care Stocks Moving In Monday's Intraday Session
Multiple health care and biotech stocks experienced significant price movements, with some stocks seeing substantial gains while others faced sharp declines during Monday's trading session.
09/29/2025, 1:06 PM • Benzinga
Peers
Statistics
MoreInformation as of 06/03/2026
Company Profile
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.
Key Executives
- T. Ronan Kennedy
- Bradley Whitford
- Sibyl Swift
- Francisco Mangual
- Lance Blundell
Current Ownership Distribution
- Mutual Funds59.2M (49.04%)
- Institutions57.1M (47.34%)
- Insiders4.4M (3.61%)
- Other0 (0.00%)